Merck’s hepatitis B vaccine trial on hold

March 28, 2008
Sales and Marketing

US regulators have placed a 'clinical hold' on one of the trials for Merck's hepatitis B vaccine Heplisav, raising questions …

Boehringer Ingelheim’s Pradaxa approved in Europe

March 28, 2008
Sales and Marketing

European regulators have approved Boehringer Ingelheim's novel anti-clotting pill Pradaxa, paving the way it to be launched in the coming …

Pharming’s orphan drug receives second setback in Europe

March 26, 2008
Sales and Marketing HAE, Pharming

Dutch biotech company Pharming has suffered a blow, after its lead product Rhucin was rejected by European regulators for a …

NHS Trusts to promote their services to the public

March 25, 2008
Medical Communications

All patients needing routine hospital care will soon be able to choose from any approved NHS trust in the country. …

Latest news from Datamonitor

March 25, 2008
Sales and Marketing em

Faced with dwindling growth rates in the US and Europe, drug companies are turning their attention towards emerging pharmaceutical markets …

Early access to experimental drugs for terminally ill

March 25, 2008
Sales and Marketing

Terminally ill cancer patients are to get early access to developmental drugs in a bid to halve the time it …

GSK consolidates Cervarix PR ahead of crucial vaccine decision

March 25, 2008
Medical Communications

GlaxoSmithKline has reorganised the PR support for its cervical cancer vaccine Cervarix, choosing just one agency to handle the UK …

Latest news from Datamonitor

March 20, 2008
Sales and Marketing

With pharmaceutical companies struggling to maintain pipelines and portfolios with products developed in-house, organizations are increasingly turning to licensing to …

Onwards and upwards

March 20, 2008
Business Services career, planning, recruitment

In an era of elusive blockbusters, job cuts and growing insecurity in the pharma industry, the skills you need to …

AZ and Silence to collaborate on gene technology

March 20, 2008
Research and Development

AstraZeneca has signed a deal with UK biotech firm Silence Therapeutics to develop a range of novel approaches for the …

Nexium and Seroquel face US generic fight

March 20, 2008
Sales and Marketing

AstraZeneca is to face a crucial court battle over one of its biggest brands, Seroquel. Generics companies Teva and Sandoz …

Manchester selected for translational medicine centre

March 19, 2008
Research and Development

A new Biomedical Research Centre of excellence is to be created in Manchester to help the UK bridge the gap …

Side-effect caution to delay Tyverb

March 19, 2008
Research and Development

GlaxoSmithKline has informed regulators in the US and Europe that a small number of patients taking its new breast cancer …

Industry doubts government commitment to innovation

March 19, 2008
Sales and Marketing

The government has unveiled high plans to make the UK a world leader in innovation, but the pharmaceutical industry remains …

Practice based commissioning and NICE workshops launched

March 14, 2008

The impact of practice-based commissioning (PBC) on how NICE guidance is implemented will be explored in a series of regional …

Celgene buys up Pharmion

March 14, 2008
Sales and Marketing

Specialist biopharma company Celgene has bought Pharmion for $2.9 billion in a bid to become a global leader in haematology …

Spend NHS surplus on out-of-hours, say primary care leaders

March 14, 2008

Primary care leaders have called for some of the predicted billions in the NHS budget surplus to be spent on …

Workshops to bring together industry and NHS researchers

March 14, 2008
ABPI

The pharma industry and interested NHS researchers will come together in a new initiative aimed at increasing and accelerating clinical …

Why should we listen to you?

March 12, 2008
Medical Communications, Sales and Marketing industry relations, marketing, stakeholders

Last month, Pharmafocus showed how market access can be a platform to build a cohesive strategy that brings together sales, …

Latest news from Datamonitor

March 12, 2008
Sales and Marketing

Type 2 diabetes driving epidemic Type 2 diabetes poses one of the greatest public health threats of the 21st century. …

The Gateway to Local Adoption Series

Latest content